Welcome to our dedicated page for Quaker Chemical SEC filings (Ticker: KWR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Quaker Houghton (NYSE: KWR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Quaker Houghton, also known in filings as Quaker Chemical Corporation, is a global industrial process fluids company serving steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking customers across the Americas, EMEA, and Asia/Pacific segments.
Through this page, readers can review core documents such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe the company’s industrial process fluids portfolio, geographic segments, risk factors, and management’s discussion and analysis of financial condition and results of operations. Current reports on Form 8-K, including those referenced in connection with quarterly earnings releases and leadership changes, provide timely updates on material events such as financial results, executive appointments, and other significant corporate developments.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand items such as net sales trends by segment, non-GAAP performance metrics like adjusted EBITDA, and the impact of acquisitions on Quaker Houghton’s financial profile. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q, and 8-K filings are available as they are posted.
Users can also access information related to executive and board changes reported under Item 5.02 of Form 8-K, as well as other governance and compensation disclosures that may appear in proxy and related filings. For investors analyzing KWR stock, this page offers a centralized view of Quaker Houghton’s official regulatory record, with AI tools that simplify complex financial and legal language into more accessible insights.
Quaker Chemical senior vice president Renato Carvalho reported routine equity compensation activity and related tax withholding. On March 15, 2026, he acquired a total of 264 shares of Common Stock upon vesting and settlement of previously granted Restricted Stock Units (RSUs) and Dividend Equivalent Rights tied to Performance Stock Units awarded on March 15, 2023.
He also received a new grant of 844 time-based RSUs, each representing a contingent right to one share of Quaker Chemical common stock with associated dividend equivalent rights. In addition, he was granted 63 shares of Common Stock as a separate award.
To satisfy withholding tax obligations upon partial vesting of certain RSUs and PSUs under the company’s Long-Term Performance Incentive Plan, 126 shares of Common Stock were surrendered at a price of $118.45 per share. Following these transactions, Carvalho directly holds 855 shares of Common Stock, and the derivativeSummary indicates no remaining derivative positions reported in this filing.
Quaker Chemical EVP Jeewat Bijlani increased his equity stake through vesting awards and related tax withholding. On March 15, 2026, he acquired 1,568 shares of common stock through the exercise and settlement of restricted stock units and dividend equivalent rights, all at a stated price of $0.00 per share.
He also received 2,195 new time-based restricted stock units as a compensation grant and 1,297 shares of common stock, both at no cash cost to him. To cover withholding taxes on vested performance and restricted stock awards, 923 shares of common stock were surrendered at $118.45 per share. After these transactions, he directly holds 6,748 shares of common stock, plus 61 shares held indirectly through a 401(k) plan.
Quaker Chemical CEO and President Joseph A. Berquist reported multiple equity-compensation transactions dated March 15, 2026. He acquired 3,377 shares of common stock through vesting and settlement of restricted stock units, performance stock units, and dividend equivalent rights, all converting one-for-one into common shares.
Berquist also received a new grant of 11,143 time-based restricted stock units as a long-term incentive award. To cover withholding taxes on these vestings, 1,623 shares of common stock were surrendered at a value of $118.45 per share. Following these transactions, he directly holds 15,393 common shares and indirectly holds 274 shares through a 401(k) plan.
Quaker Chemical Corporation, also known as Quaker Houghton, reported that effective March 9, 2026, Jeffrey Fleck no longer serves as Senior Vice President and Chief Global Operations Officer.
The company states that his departure is not due to any disagreement with the company. His separation is classified as an involuntary termination without cause for purposes of plan benefits and contractual entitlements under his January 23, 2023 employment agreement. Subject to signing a customary release of claims, he will receive severance payments and benefits consistent with the terms previously described in the company’s March 31, 2025 proxy statement.
Quaker Houghton, a global leader in industrial process fluids, outlines its business, strategy and risks in its annual report. The company serves steel, aluminum, automotive, aerospace and other industrial markets through three geographic segments: Americas, EMEA, and Asia/Pacific, with major product lines like metal removal fluids, rolling lubricants, hydraulic fluids and surface solutions.
Recent years featured multiple acquisitions, including Dipsol, Natech, CSI, Sutai and IKV, to expand surface treatment, first-fill greases and regional presence. Quaker Houghton invested $60.7 million in research and development in 2025, employs about 4,700 people, emphasizes sustainability and safety, and highlights extensive risk factors spanning cyclical demand, raw materials, currency exposure, regulation, cybersecurity and an $88.8 million goodwill impairment in its EMEA segment.
Quaker Houghton reported higher fourth-quarter 2025 results, with net sales of $468.5 million, up 6% year over year. GAAP net income rose to $20.7 million, or $1.18 per diluted share, while non-GAAP earnings were $28.9 million, or $1.65 per share.
For full-year 2025, net sales reached $1.89 billion, but the company posted a GAAP net loss of $2.5 million, or $0.14 per share, driven by an $88.8 million impairment and $35.1 million of restructuring charges. Non-GAAP net income was $123.2 million, or $7.02 per share, and adjusted EBITDA was $299.2 million. Quaker Houghton generated $136.5 million of operating cash flow, ended the year with $691.4 million of net debt and a 2.3x leverage ratio, and returned $75.9 million to shareholders through dividends and share repurchases.
Quaker Chemical director Michael F. Barry reported stock option and related share transactions. On February 10, 2026, he exercised 8,212 employee stock options at an exercise price of $136.64 per share, receiving the same number of common shares.
On the same date, 6,876 common shares were disposed of at $176.06 per share to cover the exercise price or tax obligations, a non‑open‑market transaction coded "F." After these transactions, Barry directly owned 78,010 shares of Quaker Chemical common stock.
Quaker Chemical executive Kevin K. Meagher received an equity grant in the form of restricted stock units tied to the company’s common stock. On January 15, 2026, he was awarded 1,898 time-based restricted stock units under the company’s Long-Term Performance Incentive Plan at a grant price of $0 per unit, all held as a direct position.
The award will vest in three equal annual installments beginning on January 15, 2027, meaning additional shares of KWR common stock may be delivered each year as the units vest. Each restricted stock unit represents the right to receive one share of KWR common stock, and dividend equivalent rights accrue on these units when and as dividends are paid on KWR’s common stock.
Quaker Chemical Corporation insider ownership update: Kevin K. Meagher, who serves as VP, R&D - Advanced Solutions at Quaker Chemical Corporation (ticker KWR), filed an initial insider ownership report. The filing states that no securities of the company are beneficially owned by him at this time, and there are no non-derivative or derivative holdings listed in the ownership tables.
Quaker Chemical Corp reported that an officer serving as SVP and CHRO completed equity transactions on December 15, 2025. The officer converted 327 restricted stock units into common stock and settled 5 dividend equivalent rights, each economically equivalent to one share of KWR common stock.
After these transactions and a disposition of 92 common shares at $138.99 per share, the officer directly beneficially owned 719 shares of Quaker Chemical common stock and 655 restricted stock units. The restricted stock units were part of a 982-unit special time-based grant that vests in three equal installments beginning on December 15, 2025.